FTX Co-founder Seeks Judicial Consent for Adderall during Ongoing Criminal Trial
Summary:
FTX Co-founder Sam Bankman-Fried is seeking permission from a US judge to take Adderall during his ongoing criminal trial due to focus and concentration issues. His legal team requested a halt in court proceedings if the medication proves ineffective or if he isn't able to take it. They have also appealed to the judge to allow them to provide the medication at the court during the trial.
Sam Bankman-Fried, Co-founder of FTX, is reportedly seeking permission from a US Judge for the administration of Adderall, citing concentration issues during his ongoing criminal court case. His legal representatives sent a letter to Judge Lewis Kaplan, located within the New York District, on October 15. The correspondence requested Bankman-Fried should be allowed to take a 20mg dosage of the medication, lasting 12 hours, prior to his next court appearance on October 16.
The legal team urge the need for Adderall, elaborating that the absence of the medication during the courtroom hours is hindering the concentration abilities of their client, Bankman-Fried. They contend this is affecting his capacity to engage and contribute effectively to his own defense during the trial. Despite the medication shortfall, the former CEO of FTX is endeavoring to stay focused throughout the trial proceedings, as per the contents of the letter.
The effectiveness of the extended release Adderall, should Bankman-Fried be allowed to take it, cannot yet be determined, his lawyers highlight. They have suggested a halt in the trial proceedings for one day, Tuesday, October 17, if Bankman-Fried is either unable to take the medication or if it proves ineffective. This pause would be used to find a more efficient solution for the remainder of the trial.
In the same vein, they pleaded with Judge Kaplan to permit them to provide Adderall to their client directly at the District Court during the trial. It's on the record that they tried to resolve the situation through the Bureau of Prisons, but their attempts at communication, through multiple emails and voicemails, have remained unanswered.
Published At
10/16/2023 1:36:21 AM
Disclaimer: Algoine does not endorse any content or product on this page. Readers should conduct their own research before taking any actions related to the asset, company, or any information in this article and assume full responsibility for their decisions. This article should not be considered as investment advice. Our news is prepared with AI support.
Do you suspect this content may be misleading, incomplete, or inappropriate in any way, requiring modification or removal?
We appreciate your report.